Savannah Chrisley’s prescription weight loss website was flagged by the FDA over potentially misleading claims about GLP-1s. Savannah, 28, got a warning letter last month due to the wording she used while promoting semaglutide and tirzepatide products on her site, GoodGirlRX, particularly phrases including “FDA-approved meds,” “FDA-approved options” and “clinically proven GLP-1 results.” The reality star was reprimanded for implying that her products had been “evaluated for safety and effectiveness when they have not,” according to TMZ. The outlet was first to report the news on Tuesday, March...

1 hour ago

On HALO